Personal information

Other IDs

Scopus Author ID: 53876888900
ResearcherID: S-4475-2017
Scopus Author ID: 57205594640
Loop profile: 1849215

Keywords

genomics

Countries

United States

Activities

Collapse all

Employment (6)

Northwestern University - Chicago: Chicago, IL, US

2015-02-01 to present | Assistant Professor (Biochemistry and Molecular Genetics)
Employment
Source: Self-asserted source
Elizabeth Bartom

Technion Israel Institute of Technology: Haifa, Haifa, IL

2013-09 to 2014-09 | Bioinformatician (Bioinformatics Knowledge Unit)
Employment
Source: Self-asserted source
Elizabeth Bartom

University of Chicago: Chicago, IL, US

2012-04 to 2014-08 | Bioinformatician (Center for Research Informatics)
Employment
Source: Self-asserted source
Elizabeth Bartom

University of Chicago: Chicago, IL, US

2010-04 to 2012-04 | Bioinformatician (University of Chicago Comprehensive Cancer Center)
Employment
Source: Self-asserted source
Elizabeth Bartom

Broad Institute: Cambridge, MA, US

2006-10 to 2010-01 | Postdoctoral Fellow
Employment
Source: Self-asserted source
Elizabeth Bartom

Harvard University: Cambridge, MA, US

2004-06 to 2006-10 | Postdoctoral Fellow (Bauer Center for Genomics Research)
Employment
Source: Self-asserted source
Elizabeth Bartom

Education and qualifications (2)

Cold Spring Harbor Laboratory School of Biological Sciences: Cold Spring Harbor, NY, US

1999-09 to 2004-05 | PhD
Education
Source: Self-asserted source
Elizabeth Bartom

The Evergreen State College: Olympia, WA, US

1995-09 to 1999-06 | Combined BA / BS
Education
Source: Self-asserted source
Elizabeth Bartom

Funding (2)

SPORE for Translational Approaches to Brain Cancer

2018-08-17 to 2023-07-31 | Grant
National Cancer Institute (Rockville, US)
URL: https://app.dimensions.ai/details/grant/grant.7725103
GRANT_NUMBER: P50CA221747
Source: Self-asserted source
Elizabeth Bartom via DimensionsWizard

Bioinformatic Analysis of Next Generation Sequencing Data from Cancer Cells

2017-09-19 to 2022-08-31 | Grant
National Cancer Institute (Rockville, US)
URL: https://app.dimensions.ai/details/grant/grant.7072584
GRANT_NUMBER: R50CA221848
Source: Self-asserted source
Elizabeth Bartom via DimensionsWizard

Works (50 of 122)

Items per page:
Page 1 of 3

Reprogramming SREBP1-dependent lipogenesis and inflammation in high-risk breast with licochalcone A: a novel path to cancer prevention

2024-05-21 | Preprint
DOI: 10.1101/2024.05.20.595011
Contributors: Atieh Hajirahimkhan; Elizabeth T. Bartom; Carolina H Chung; Xingyu Guo; Kyli Berkley; Oukseub Lee; Ruohui Chen; Wonhwa Cho; Sriram Chandrasekaran; Susan E. Clare et al.
Source: check_circle
Crossref

Loss of thymocyte competition underlies the tumor suppressive functions of the E2a transcription factor in T-ALL

Leukemia
2024-03 | Journal article
DOI: 10.1038/s41375-023-02123-4
Contributors: Geoffrey Parriott; Emma Hegermiller; Rosemary E. Morman; Cameron Frank; Caner Saygin; Wendy Stock; Elizabeth T. Bartom; Barbara L. Kee
Source: check_circle
Crossref

Death Induced by Survival gene Elimination (DISE) correlates with neurotoxicity in Alzheimer’s disease and aging

Nature Communications
2024-01-18 | Journal article
DOI: 10.1038/s41467-023-44465-8
Contributors: Bidur Paudel; Si-Yeon Jeong; Carolina Pena Martinez; Alexis Rickman; Ashley Haluck-Kangas; Elizabeth T. Bartom; Kristina Fredriksen; Amira Affaneh; John A. Kessler; Joseph R. Mazzulli et al.
Source: check_circle
Crossref

Breast cancer prevention with liquiritigenin from licorice through the inhibition of aromatase and protein biosynthesis in high-risk women’s breast tissue

Scientific Reports
2023 | Journal article
DOI: 10.1038/s41598-023-34762-z
EID:

2-s2.0-85160650179

Part of ISSN: 20452322
Contributors: Hajirahimkhan, A.; Howell, C.; Bartom, E.T.; Dong, H.; Lantvit, D.D.; Xuei, X.; Chen, S.-N.; Pauli, G.F.; Bolton, J.L.; Clare, S.E. et al.
Source: Self-asserted source
Elizabeth Bartom via Scopus - Elsevier

CD95/Fas ligand mRNA is toxic to cells through more than one mechanism

Molecular Biomedicine
2023 | Journal article
DOI: 10.1186/s43556-023-00119-1
EID:

2-s2.0-85153250386

Part of ISSN: 26628651
Contributors: Haluck-Kangas, A.; Fink, M.; Bartom, E.T.; Peter, M.E.
Source: Self-asserted source
Elizabeth Bartom via Scopus - Elsevier
grade
Preferred source (of 3)‎

Checkpoint kinase 1/2 inhibition potentiates anti-tumoral immune response and sensitizes gliomas to immune checkpoint blockade

Nature Communications
2023 | Journal article
DOI: 10.1038/s41467-023-36878-2
EID:

2-s2.0-85150770161

Part of ISSN: 20411723
Contributors: Dmello, C.; Zhao, J.; Chen, L.; Gould, A.; Castro, B.; Arrieta, V.A.; Zhang, D.Y.; Kim, K.-S.; Kanojia, D.; Zhang, P. et al.
Source: Self-asserted source
Elizabeth Bartom via Scopus - Elsevier

Loss of thymocyte competition underlies the tumor suppressive functions of the E2a transcription factor in T lymphocyte acute lymphoblastic leukemia

bioRxiv
2023 | Other
DOI: 10.1101/2023.04.23.537993
EID:

2-s2.0-85160303163

Part of ISSN: 26928205
Contributors: Parriott, G.; Hegermiller, E.; Morman, R.E.; Frank, C.; Saygin, C.; Stock, W.; Bartom, E.T.; Kee, B.L.
Source: Self-asserted source
Elizabeth Bartom via Scopus - Elsevier

TGF-β Promotes the Postselection Thymic Development and Peripheral Function of IFN-γ–Producing Invariant NKT cells

The Journal of Immunology
2023-11-01 | Journal article
DOI: 10.4049/jimmunol.2200809
Contributors: Roxroy C Morgan; Cameron Frank; Munmun Greger; Mary Attaway; Mikael Sigvardsson; Elizabeth T Bartom; Barbara L Kee
Source: check_circle
Crossref

Iron drives anabolic metabolism through active histone demethylation and mTORC1

Nature Cell Biology
2023-10 | Journal article
DOI: 10.1038/s41556-023-01225-6
Contributors: Jason S. Shapiro; Hsiang-Chun Chang; Yuki Tatekoshi; Zibo Zhao; Zohra Sattar Waxali; Bong Jin Hong; Haimei Chen; Justin A. Geier; Elizabeth T. Bartom; Adam De Jesus et al.
Source: check_circle
Crossref

Nore1 inhibits age-associated myeloid lineage skewing and clonal hematopoiesis but facilitates termination of emergency (stress) granulopoiesis

Journal of Biological Chemistry
2023-07 | Journal article
DOI: 10.1016/j.jbc.2023.104867
Contributors: Olatundun Williams; Liping Hu; Weiqi Huang; Priyam Patel; Elizabeth T. Bartom; Ling Bei; Elizabeth Hjort; Christina Hijiya; Elizabeth A. Eklund
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Therapeutic targeting of metabolic vulnerabilities in cancers with MLL3/4-COMPASS epigenetic regulator mutations

Journal of Clinical Investigation
2023-07-03 | Journal article
DOI: 10.1172/JCI169993
Contributors: Zibo Zhao; Kaixiang Cao; Jun Watanabe; Cassandra N. Philips; Jacob M. Zeidner; Yukitomo Ishi; Qixuan Wang; Sarah R. Gold; Katherine Junkins; Elizabeth T. Bartom et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Data from Targeting ULK1 Decreases IFNγ-Mediated Resistance to Immune Checkpoint Inhibitors

2023-04-03 | Preprint
DOI: 10.1158/1541-7786.c.6534780
Contributors: Sarah E. Fenton; Markella Zannikou; Liliana Ilut; Mariafausta Fischietti; Chunni Ji; Chidera V. Oku; Curt M. Horvath; I. Caroline Le Poole; Marcus Bosenberg; Elizabeth T. Bartom et al.
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

Supplementary Figures and Supplementary Materials and Methods with References from Targeting ULK1 Decreases IFNγ-Mediated Resistance to Immune Checkpoint Inhibitors

2023-04-03 | Preprint
DOI: 10.1158/1541-7786.22495227.v1
Contributors: Sarah E. Fenton; Markella Zannikou; Liliana Ilut; Mariafausta Fischietti; Chunni Ji; Chidera V. Oku; Curt M. Horvath; I. Caroline Le Poole; Marcus Bosenberg; Elizabeth T. Bartom et al.
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

Supplementary Table 1 from Targeting ULK1 Decreases IFNγ-Mediated Resistance to Immune Checkpoint Inhibitors

2023-04-03 | Preprint
DOI: 10.1158/1541-7786.22495224.v1
Contributors: Sarah E. Fenton; Markella Zannikou; Liliana Ilut; Mariafausta Fischietti; Chunni Ji; Chidera V. Oku; Curt M. Horvath; I. Caroline Le Poole; Marcus Bosenberg; Elizabeth T. Bartom et al.
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

Targeting ULK1 Decreases IFNγ-Mediated Resistance to Immune Checkpoint Inhibitors

Molecular Cancer Research
2023-04-01 | Journal article
DOI: 10.1158/1541-7786.MCR-22-0684
Contributors: Sarah E. Fenton; Markella Zannikou; Liliana Ilut; Mariafausta Fischietti; Chunni Ji; Chidera V. Oku; Curt M. Horvath; I. Caroline Le Poole; Marcus Bosenberg; Elizabeth T. Bartom et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Data from PAX9 Determines Epigenetic State Transition and Cell Fate in Cancer

2023-03-30 | Preprint
DOI: 10.1158/0008-5472.c.6493350.v1
Contributors: Zibo Zhao; Aileen P. Szczepanski; Natsumi Tsuboyama; Hiam Abdala-Valencia; Young Ah Goo; Benjamin D. Singer; Elizabeth T. Bartom; Feng Yue; Lu Wang
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

Data from The Ratio of Toxic-to-Nontoxic miRNAs Predicts Platinum Sensitivity in Ovarian Cancer

2023-03-30 | Preprint
DOI: 10.1158/0008-5472.c.6487281
Contributors: Monal Patel; Yinu Wang; Elizabeth T. Bartom; Rohin Dhir; Kenneth P. Nephew; Daniela Matei; Andrea E. Murmann; Ernst Lengyel; Marcus E. Peter
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

Figures S1-SF9 from The Ratio of Toxic-to-Nontoxic miRNAs Predicts Platinum Sensitivity in Ovarian Cancer

2023-03-30 | Preprint
DOI: 10.1158/0008-5472.22361509
Contributors: Monal Patel; Yinu Wang; Elizabeth T. Bartom; Rohin Dhir; Kenneth P. Nephew; Daniela Matei; Andrea E. Murmann; Ernst Lengyel; Marcus E. Peter
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

Supplementary Data from PAX9 Determines Epigenetic State Transition and Cell Fate in Cancer

2023-03-30 | Preprint
DOI: 10.1158/0008-5472.22362363.v1
Contributors: Zibo Zhao; Aileen P. Szczepanski; Natsumi Tsuboyama; Hiam Abdala-Valencia; Young Ah Goo; Benjamin D. Singer; Elizabeth T. Bartom; Feng Yue; Lu Wang
Source: check_circle
Crossref
grade
Preferred source (of 5)‎

Table S3-S5 from The Ratio of Toxic-to-Nontoxic miRNAs Predicts Platinum Sensitivity in Ovarian Cancer

2023-03-30 | Preprint
DOI: 10.1158/0008-5472.22361506
Contributors: Monal Patel; Yinu Wang; Elizabeth T. Bartom; Rohin Dhir; Kenneth P. Nephew; Daniela Matei; Andrea E. Murmann; Ernst Lengyel; Marcus E. Peter
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

Table S4 from The Ratio of Toxic-to-Nontoxic miRNAs Predicts Platinum Sensitivity in Ovarian Cancer

2023-03-30 | Preprint
DOI: 10.1158/0008-5472.22361503
Contributors: Monal Patel; Yinu Wang; Elizabeth T. Bartom; Rohin Dhir; Kenneth P. Nephew; Daniela Matei; Andrea E. Murmann; Ernst Lengyel; Marcus E. Peter
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

Table S5 from The Ratio of Toxic-to-Nontoxic miRNAs Predicts Platinum Sensitivity in Ovarian Cancer

2023-03-30 | Preprint
DOI: 10.1158/0008-5472.22361500.v1
Contributors: Monal Patel; Yinu Wang; Elizabeth T. Bartom; Rohin Dhir; Kenneth P. Nephew; Daniela Matei; Andrea E. Murmann; Ernst Lengyel; Marcus E. Peter
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

Table ST1 and ST2 from The Ratio of Toxic-to-Nontoxic miRNAs Predicts Platinum Sensitivity in Ovarian Cancer

2023-03-30 | Preprint
DOI: 10.1158/0008-5472.22361497
Contributors: Monal Patel; Yinu Wang; Elizabeth T. Bartom; Rohin Dhir; Kenneth P. Nephew; Daniela Matei; Andrea E. Murmann; Ernst Lengyel; Marcus E. Peter
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

Table STL3 from The Ratio of Toxic-to-Nontoxic miRNAs Predicts Platinum Sensitivity in Ovarian Cancer

2023-03-30 | Preprint
DOI: 10.1158/0008-5472.22361494.v1
Contributors: Monal Patel; Yinu Wang; Elizabeth T. Bartom; Rohin Dhir; Kenneth P. Nephew; Daniela Matei; Andrea E. Murmann; Ernst Lengyel; Marcus E. Peter
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

Tables S1 and S2 from The Ratio of Toxic-to-Nontoxic miRNAs Predicts Platinum Sensitivity in Ovarian Cancer

2023-03-30 | Preprint
DOI: 10.1158/0008-5472.22361491.v1
Contributors: Monal Patel; Yinu Wang; Elizabeth T. Bartom; Rohin Dhir; Kenneth P. Nephew; Daniela Matei; Andrea E. Murmann; Ernst Lengyel; Marcus E. Peter
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

Tables ST3-ST5 from The Ratio of Toxic-to-Nontoxic miRNAs Predicts Platinum Sensitivity in Ovarian Cancer

2023-03-30 | Preprint
DOI: 10.1158/0008-5472.22361488.v1
Contributors: Monal Patel; Yinu Wang; Elizabeth T. Bartom; Rohin Dhir; Kenneth P. Nephew; Daniela Matei; Andrea E. Murmann; Ernst Lengyel; Marcus E. Peter
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

A synthetic lethality screen reveals ING5 as a genetic dependency of catalytically dead Set1A/COMPASS in mouse embryonic stem cells

Proceedings of the National Academy of Sciences of the United States of America
2022 | Journal article
DOI: 10.1073/pnas.2118385119
EID:

2-s2.0-85129781140

Part of ISSN: 10916490 00278424
Contributors: Cenik, B.K.; Sze, C.C.; Ryan, C.A.; Das, S.; Cao, K.; Douillet, D.; Rendleman, E.J.; Zha, D.; Khan, N.H.; Bartom, E. et al.
Source: Self-asserted source
Elizabeth Bartom via Scopus - Elsevier

Contribution of 6mer seed toxicity to HIV-1 induced cytopathicity

bioRxiv
2022 | Other
DOI: 10.1101/2022.10.01.510471
EID:

2-s2.0-85142857800

Part of ISSN: 26928205
Contributors: Vaidyanathan, A.; Taylor, H.E.; Hope, T.J.; D'Aquila, R.T.; Bartom, E.T.; Hultquist, J.F.; Peter, M.E.
Source: Self-asserted source
Elizabeth Bartom via Scopus - Elsevier

DISE contributes to neurotoxicity in Alzheimer's disease

bioRxiv
2022 | Other
DOI: 10.1101/2022.09.08.507157
EID:

2-s2.0-85164049813

Part of ISSN: 26928205
Contributors: Paudel, B.; Jeong, S.-Y.; Martinez, C.P.; Rickman, A.; Haluck-Kangas, A.; Bartom, E.T.; Fredriksen, K.; Affaneh, A.; Kessler, J.A.; Mazzulli, J.R. et al.
Source: Self-asserted source
Elizabeth Bartom via Scopus - Elsevier

Identification of the toxic 6mer seed consensus for human cancer cells

Scientific Reports
2022 | Journal article
DOI: 10.1038/s41598-022-09051-w
EID:

2-s2.0-85127028765

Part of ISSN: 20452322
Contributors: Patel, M.; Bartom, E.T.; Paudel, B.; Kocherginsky, M.; O’Shea, K.L.; Murmann, A.E.; Peter, M.E.
Source: Self-asserted source
Elizabeth Bartom via Scopus - Elsevier

Modeling Therapy-Driven Evolution of Glioblastoma with Patient-Derived Xenografts

Cancers
2022 | Journal article
DOI: 10.3390/cancers14225494
EID:

2-s2.0-85142515322

Part of ISSN: 20726694
Contributors: McCord, M.; Bartom, E.; Burdett, K.; Baran, A.; Eckerdt, F.D.; Balyasnikova, I.V.; McCortney, K.; Sears, T.; Cheng, S.-Y.; Sarkaria, J.N. et al.
Source: Self-asserted source
Elizabeth Bartom via Scopus - Elsevier

Oncogenic and Tumor Suppressor Functions for Lymphoid Enhancer Factor 1 in E2a<sup>-/-</sup> T Acute Lymphoblastic Leukemia

Frontiers in Immunology
2022 | Journal article
DOI: 10.3389/fimmu.2022.845488
EID:

2-s2.0-85127473429

Part of ISSN: 16643224
Contributors: Carr, T.; McGregor, S.; Dias, S.; Verykokakis, M.; Le Beau, M.M.; Xue, H.-H.; Sigvardsson, M.; Bartom, E.T.; Kee, B.L.
Source: Self-asserted source
Elizabeth Bartom via Scopus - Elsevier

SF3B1 homeostasis is critical for survival and therapeutic response in T cell leukemia

Science Advances
2022 | Journal article
DOI: 10.1126/sciadv.abj8357
EID:

2-s2.0-85123304555

Part of ISSN: 23752548
Contributors: Han, C.; Khodadadi-Jamayran, A.; Lorch, A.H.; Jin, Q.; Serafin, V.; Zhu, P.; Politanska, Y.; Sun, L.; Gutierrez-Diaz, B.T.; Pryzhkova, M.V. et al.
Source: Self-asserted source
Elizabeth Bartom via Scopus - Elsevier

Transforming growth factor-β promotes the postselection thymic development and peripheral function of interferon-γ-producing invariant natural killer T cells

bioRxiv
2022 | Other
DOI: 10.1101/2022.10.23.513409
EID:

2-s2.0-85143679149

Part of ISSN: 26928205
Contributors: Morgan, R.C.; Frank, C.; Greger, M.; Sigvardsson, M.; Bartom, E.T.; Kee, B.L.
Source: Self-asserted source
Elizabeth Bartom via Scopus - Elsevier

The length of uninterrupted CAG repeats in stem regions of repeat disease associated hairpins determines the amount of short CAG oligonucleotides that are toxic to cells through RNA interference

Cell Death & Disease
2022-12-30 | Journal article
DOI: 10.1038/s41419-022-05494-1
Contributors: Andrea E. Murmann; Monal Patel; Si-Yeon Jeong; Elizabeth T. Bartom; A. Jennifer Morton; Marcus E. Peter
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Iron Drives Anabolic Metabolism Through Active Histone Demethylation and mTORC1

2022-09-14 | Preprint
DOI: 10.21203/rs.3.rs-2042947/v1
Contributors: Jason Shapiro; Hsiang-Chun Chang; Zibo Zhao; Zohra Waxali; Bong Jin Hong; Haimei Chen; Justin Geier; Elizabeth Bartom; Adam De Jesus; Farnaz Keyhani-Nejad et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Placental dysfunction influences fetal monocyte subpopulation gene expression in preterm birth

JCI Insight
2022-06-08 | Journal article
DOI: 10.1172/jci.insight.155482
Contributors: Abhineet M. Sharma; Robert Birkett; Erika T. Lin; Linda M. Ernst; William A. Grobman; Suchitra Swaminathan; Hiam Abdala-Valencia; Alexander V. Misharin; Elizabeth T. Bartom; Karen K. Mestan
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

SPOROS: A pipeline to analyze DISE/6mer seed toxicity

PLOS Computational Biology
2022-03-31 | Journal article
DOI: 10.1371/journal.pcbi.1010022
Contributors: Elizabeth T. Bartom; Zhaolei Zhang; Masha Kocherginsky; Bidur Paudel; Aparajitha Vaidyanathan; Ashley Haluck-Kangas; Monal Patel; Kaitlyn L. O’Shea; Andrea E. Murmann; Marcus E. Peter
Source: check_circle
Crossref
grade
Preferred source (of 4)‎

Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia

Nature
2021 | Journal article
DOI: 10.1038/s41586-020-03148-w
EID:

2-s2.0-85099648337

Part of ISSN: 14764687 00280836
Contributors: Grant, R.A.; Morales-Nebreda, L.; Markov, N.S.; Swaminathan, S.; Querrey, M.; Guzman, E.R.; Abbott, D.A.; Donnelly, H.K.; Donayre, A.; Goldberg, I.A. et al.
Source: Self-asserted source
Elizabeth Bartom via Scopus - Elsevier

Oncogenic and tumor suppressor functions for lymphoid enhancer factor 1 in a murine model of T acute lymphoblastic leukemia

bioRxiv
2021 | Other
DOI: 10.1101/2021.11.08.467708
EID:

2-s2.0-85121395454

Part of ISSN: 26928205
Contributors: Carr, T.; McGregor, S.; Dias, S.; Verykokakis, M.; LeBeau, M.M.; Xue, H.-H.; Bartom, E.T.; Kee, B.L.
Source: Self-asserted source
Elizabeth Bartom via Scopus - Elsevier

PAX9 Determines Epigenetic State Transition and Cell Fate in Cancer

Cancer Research
2021-09-15 | Journal article
DOI: 10.1158/0008-5472.CAN-21-1114
Contributors: Zibo Zhao; Aileen P. Szczepanski; Natsumi Tsuboyama; Hiam Abdala-Valencia; Young Ah Goo; Benjamin D. Singer; Elizabeth T. Bartom; Feng Yue; Lu Wang
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

The Ratio of Toxic-to-Nontoxic miRNAs Predicts Platinum Sensitivity in Ovarian Cancer

Cancer Research
2021-08-01 | Journal article
DOI: 10.1158/0008-5472.CAN-21-0953
Contributors: Monal Patel; Yinu Wang; Elizabeth T. Bartom; Rohin Dhir; Kenneth P. Nephew; Daniela Matei; Andrea E. Murmann; Ernst Lengyel; Marcus E. Peter
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

The transcriptional repressor ID2 supports natural killer cell maturation by controlling TCF1 amplitude

Journal of Experimental Medicine
2021-06-07 | Journal article
DOI: 10.1084/jem.20202032
Contributors: Zhong-Yin Li; Rosemary E. Morman; Emma Hegermiller; Mengxi Sun; Elizabeth T. Bartom; Mark Maienschein-Cline; Mikael Sigvardsson; Barbara L. Kee
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Epigenomic landscape and 3D genome structure in pediatric high-grade glioma

Science Advances
2021-06-04 | Journal article
DOI: 10.1126/sciadv.abg4126
Contributors: Juan Wang; Tina Yi-Ting Huang; Ye Hou; Elizabeth Bartom; Xinyan Lu; Ali Shilatifard; Feng Yue; Amanda Saratsis
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

The balance between toxic versus nontoxic microRNAs determines platinum sensitivity in ovarian cancer

2021-01-26 | Preprint
DOI: 10.1101/2021.01.24.427815
Contributors: Monal Patel; Yinu Wang; Elizabeth T. Bartom; Rohin Dhir; Kenneth P. Nephew; Daniela Matei; Andrea E. Murmann; Ernst Lengyel; Marcus E. Peter
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

ASXL3 bridges BRD4 to BAP1 complex and governs enhancer activity in small cell lung cancer

Genome Medicine
2020 | Journal article
DOI: 10.1186/s13073-020-00760-3
EID:

2-s2.0-85088155070

Part of ISBN:

1756994X
Contributors: Szczepanski, A.P.; Zhao, Z.; Sosnowski, T.; Goo, Y.A.; Bartom, E.T.; Wang, L.
Source: Self-asserted source
Elizabeth Bartom via Scopus - Elsevier

Effects of H3.3G34V mutation on genomic H3K36 and H3K27 methylation patterns in isogenic pediatric glioma cells

Acta Neuropathologica Communications
2020 | Journal article
DOI: 10.1186/s40478-020-01092-4
EID:

2-s2.0-85097215921

Part of ISSN: 20515960
Contributors: Huang, T.Y.-T.; Piunti, A.; Qi, J.; Morgan, M.; Bartom, E.; Shilatifard, A.; Saratsis, A.M.
Source: Self-asserted source
Elizabeth Bartom via Scopus - Elsevier

Elucidating the regulatory mechanism of Swi1 prion in global transcription and stress responses

Scientific Reports
2020 | Journal article
DOI: 10.1038/s41598-020-77993-0
Part of ISSN: 2045-2322
Contributors: Zhiqiang Du; Jeniece Regan; Elizabeth Bartom; Wei-Sheng Wu; Li Zhang; Dustin Kenneth Goncharoff; Liming Li
Source: Self-asserted source
Elizabeth Bartom via Crossref Metadata Search
grade
Preferred source (of 2)‎

HGG-26. H3G34V MUTATION AFFECTS GENOMIC H3K36 METHYLATION IN PEDIATRIC GLIOMA

Neuro-Oncology
2020 | Journal article
DOI: 10.1093/neuonc/noaa222.310
Part of ISSN: 1522-8517
Contributors: Tina Huang; Andrea Piunti; Elizabeth Bartom; Jin Qi; Rintaro Hashizume; Ali Shilatifard; Amanda Saratsis
Source: Self-asserted source
Elizabeth Bartom via Crossref Metadata Search

Identification of the toxic 6mer seed consensus in human cancer cells

bioRxiv
2020 | Other
DOI: 10.1101/2020.12.22.424040
EID:

2-s2.0-85100131745

Part of ISSN: 26928205
Contributors: Patel, M.; Bartom, E.T.; Paudel, B.; Kocherginsky, M.; O'Shea, K.L.; Murmann, A.E.; Peter, M.E.
Source: Self-asserted source
Elizabeth Bartom via Scopus - Elsevier
Items per page:
Page 1 of 3

Peer review (1 review for 1 publication/grant)

Review activity for BMC cancer (1)
How many people are using ORCID?